We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.57B
AUM Growth
+$643M
(+9.3%)
Cap. Flow
+$235M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$71M |
| 2 |
Baxter International
BAX
|
+$60.7M |
| 3 |
T-Mobile US
TMUS
|
+$60.1M |
| 4 |
Perrigo
PRGO
|
+$53.7M |
| 5 |
NRG Energy
NRG
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$68.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$53.3M |
| 3 |
Avient
AVNT
|
+$45.7M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$45.6M |
| 5 |
BHI
Baker Hughes
BHI
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.11% |
| 2 | Industrials | 11.84% |
| 3 | Consumer Discretionary | 11.65% |
| 4 | Technology | 10.61% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTRX
126
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $16.3M | 0.21% |
314,490
+26,854
| +9% | +$1.26M |
|
|
RAD
127
DELISTED
Rite Aid Corporation
RAD
| $16M | 0.21% |
+106,296
| New | +$11.8M |
|
128
Cirrus Logic
CRUS
$6.74B
| $15.9M | 0.21% |
675,735
+234,793
| +53% | +$4.73M |
|
129
Bausch Health
BHC
$2.41B
| $15.9M | 0.21% |
110,894
+57,638
| +108% | +$7.75M |
|
130
Coca-Cola
KO
$372B
| $15.8M | 0.21% |
373,057
+363,622
| +3,854% | +$15.5M |
|
131
Zebra Technologies
ZBRA
$17.6B
| $15.7M | 0.21% |
+202,976
| New | +$14.6M |
|
|
DRC
132
DELISTED
DRESSER-RAND GROUP INC
DRC
| $15.6M | 0.21% |
+191,011
| New | +$15.5M |
|
|
BTU
133
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
| $15.5M | 0.21% |
+133,787
| New | +$20M |
|
|
ALJ
134
DELISTED
Alon USA Energy Inc
ALJ
| $15.5M | 0.2% |
1,224,471
+1,207,971
| +7,321% | +$17.4M |
|
135
Papa John's
PZZA
$1.01B
| $15.5M | 0.2% |
277,232
+49,652
| +22% | +$2.43M |
|
136
Invesco
IVZ
$14.1B
| $15.4M | 0.2% |
388,954
+298,149
| +328% | +$11.7M |
|
|
CELG
137
DELISTED
Celgene Corp
CELG
| $15.3M | 0.2% |
136,729
-302,870
| -69% | -$31.9M |
|
138
H.B. Fuller
FUL
$3.17B
| $15M | 0.2% |
335,937
-5,704
| -2% | -$240K |
|
|
HSNI
139
DELISTED
HSN, Inc.
HSNI
| $15M | 0.2% |
+196,807
| New | +$13.6M |
|
140
Bright Horizons
BFAM
$3.98B
| $15M | 0.2% |
+318,075
| New | +$14M |
|
|
DNR
141
DELISTED
Denbury Resources, Inc.
DNR
| $14.9M | 0.2% |
+1,831,153
| New | +$19M |
|
142
Cintas
CTAS
$81.5B
| $14.7M | 0.19% |
+748,892
| New | +$13.5M |
|
143
Prosperity Bancshares
PB
$8.98B
| $14.5M | 0.19% |
262,588
+225,437
| +607% | +$12.8M |
|
144
Phillips 66
PSX
$82.5B
| $14.5M | 0.19% |
202,148
+74,283
| +58% | +$5.48M |
|
145
NorthWestern Energy
NWE
$4.3B
| $14.5M | 0.19% |
+255,945
| New | +$13.4M |
|
|
TARO
146
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $14.4M | 0.19% |
97,017
+63,889
| +193% | +$9.39M |
|
147
Adeia
ADEA
$3.44B
| $14.3M | 0.19% |
1,509,418
-197,237
| -12% | -$1.63M |
|
148
MGIC Investment
MTG
$6.35B
| $14.2M | 0.19% |
1,524,609
+1,346,740
| +757% | +$11.8M |
|
149
Aramark
ARMK
$14.8B
| $14.1M | 0.19% |
+626,713
| New | +$12.8M |
|
150
Regions Financial
RF
$27.3B
| $14.1M | 0.19% |
1,333,535
-2,657,765
| -67% | -$26.5M |
|
Similar funds
Marshall Wace's Q4 2014 Portfolio in Review
As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.
- Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
- Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
- Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
- Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
- Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
- Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
- Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.
Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.